-

GE Healthcare Announces Collaboration to Advance Digital Transformation of Pathology

  • A partnership to foster Enterprise imaging and pathology for oncology
  • The collaboration intends to bring a data management solution by interfacing Tribun’s Health Suite data into GE Healthcare’s products

BUC, France--(BUSINESS WIRE)--GE Healthcare and Tribun Health have entered a collaboration with the intent to provide digital pathology departmental solutions that give healthcare providers a more holistic view of patient records. The alliance intends to bring a data management solution by interfacing Tribun’s Health Suite data into GE Healthcare’s solution, such as GE Healthcare’s vendor neutral archive (VNA), Edison Datalogue. It is expected to focus on making digital pathology images and results an integrated part of the imaging patient record within the VNA; the availability of more accurate pathology reports in less time, created with the assistance of artificial intelligence (AI) provided by Tribun’s Health Suite; and fostering collaboration among pathologists and clinicians through availability of data in a consolidated location. Having pathology information is critical, especially in oncology, to enable collaboration, while improving the speed of diagnosis.

The market is rapidly evolving towards data-driven healthcare. In addition, the shortage of clinicians and increase in oncology cases globally are driving the need for development of AI to support early detection of cancers1.

"The oncology care pathway is one of the most complex with multiple steps involving a variety of specialists, complex tools, frequent decisions and large data sets,” said Nalinikanth Gollagunta, CEO of Enterprise Digital Solutions at GE Healthcare. “With this digital pathology collaboration, we continue our journey towards simplifying the oncology care pathway with improved data management, the digitization of pathology and streamlined data access. Tribun Health is an important collaborator to achieve this objective and build on GE Healthcare's enterprise approach to bringing clinical depth and AI at the point of care."

GE Healthcare and Tribun Health provide complementary solutions to streamline the oncology care pathway across the enterprise and support clinical teams delivering the best care to their patients. Edison Datalogue is GE Healthcare’s solution to unify and intelligently manage patient data, images and enterprise imaging content. The Tribun Health Suite is a leading AI-powered end-to-end computational pathology for diagnostics, prognosis and drug development. Tribun was awarded the 2022 Best in KLAS award for Digital Pathology solutions with extensive experience and has many large installations worldwide. Adding the pathology suite enables GE Healthcare to offer a full solution for patient data management.

“I am delighted with the implementation of this partnership with GE Healthcare which builds on existing relationships between our companies,” said Jean-François Pomerol, CEO at Tribun Health. “It will allow us to offer our customers a solution that interfaces easily between CaloPix, the reference solution for digital pathology, and GE's Enterprise Imaging products. This will promote interoperability of healthcare data, cooperation between clinicians and help to further clinical research.”

About GE Healthcare:
GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 48,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

About Tribun Health:
Tribun Health empowers confident decisions. The Paris based, privately held company addresses a significant, fast-growing, and unmet need for expert end-to-end pathology department digitalization. Tribun Health is a pioneer in digital pathology workflow solutions with image acquisition (Macro), image storage/organization, web-based image management system (IMS), image analysis using AI-powered deep and machine learning algorithms, remote case sharing with peer review and reporting. Tribun Health's award-winning core platform, CaloPix, is considered the industry leader winning the Best in Klas 2022 award for the most successful digital pathology provider in Europe. Tribun Health's extensive, decade long expertise drives confidence for laboratories looking for a seamless transition to a digital pathology platform. https://www.tribun.health

Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

1 The World Health Organization (WHO) estimates that there will be a shortage of 15 million health professionals by 2030.

Contacts

Media Contact:
Linh Dinh
Linh.Dinh@ge.com
408 275 5682

GE Healthcare

NYSE:GE

Release Versions

Contacts

Media Contact:
Linh Dinh
Linh.Dinh@ge.com
408 275 5682

More News From GE Healthcare

GE HealthCare launches ReadyFix fleet management solution to help enhance operational efficiency and reliable patient care

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the United States launch of ReadyFix™, a remote fleet management solution designed to help healthcare systems support device uptime. ReadyFix will seamlessly integrate with GE HealthCare’s MAC VU360™ resting ECG workstations, which are designed to deliver high-quality ECG readings that help clinicians make faster, more confident cardiac care decisions. When paired with ReadyFix, healthcare systems can leverage real-time** da...

GE HealthCare reports fourth quarter and full year 2025 financial results

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2025. GE HealthCare President and CEO Peter Arduini said, “In our third year as a public company, we’ve made great strides executing our strategy focused on precision care, growth acceleration, and business optimization. We delivered a strong quarter and year with growth in Pharmaceutical Diagnostics, Imaging, and Advanced Visualization Solutions. This...

GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced that Allia™ Moveo has received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Marking, bringing next-level mobility and precision to the interventional suite. The latest Allia platform, one of the company’s bold innovations first unveiled at the Radiological Society of North America’s (RSNA) 2025 Annual Meeting, assists clinicians in a wide range of cardiovascular, vascular, non-vascular, interventional and...
Back to Newsroom